weight loss

Will There Ever Be an Obesity Drug Blockbuster?
Motley Fool
Sun, 02/17/13 - 12:02 pm
obesity
weight loss
Arena Pharmaceuticals
Eisai
Belviq
Qsymia
Orexigen
Allergan wants to trim obesity treatment unit
The Deal
Sun, 02/10/13 - 11:51 am
Allergan
obesity
weight loss
Lap-Band
Arena Must Wait For European Approval
Seeking Alpha
Sat, 01/19/13 - 12:05 pm
Arena Pharmaceutical
European
EU
regulatory
obesity
weight loss
Weight loss: Smart fork watches how you eat | MassDevice.com On Call
Mass Device
Mon, 01/14/13 - 07:54 pm
weight loss
devices
Health
Takeda and Amylin terminate obesity compound co-development agreement
equities.com
Sat, 12/29/12 - 10:38 am
Takeda
Amylin
obesity
weight loss
Does Qsymia Have a Future After All?
Wall Street Cheat Street
Sat, 12/22/12 - 12:26 pm
Qsymia
weight loss
obesity
Vivus
Investor Enthusiasm Wanes For Obesity Drug Companies
Seeking Alpha
Sun, 12/16/12 - 11:01 am
weight loss
obesity
Arena Pharmaceuticals
Belviq
Vivus
Qsymia
The Looming EU Approval Makes Arena Pharmaceuticals Significantly Undervalued
Motley Fool
Sun, 12/16/12 - 10:18 am
Arena
Belviq
obesity
weight loss
10 Drugs Approved by the FDA in 2012 to Be Thankful For
Motley Fool
Sat, 12/15/12 - 01:28 pm
Xtandi
Medivation
prostate cancer
Stribild
Gilead Sciences
HIV
Belviq
Arena Pharmaceuticals
obesity
weight loss
Qsymia
Vivus
Kyprolis
ONYX Pharmaceuticals
Multiple Myeloma
Omontys
Affymax
anemia
Linzess
irritable bowel syndrome
Ironwood Pharmaceuticals
Bosulif
chronic myeloid leukemia
Pfizer
Amyvid
Alzheimer's disease
Eli Lilly
Eylea
macular degeneration
Regeneron
Analyst Debate: Is Arena Pharmaceuticals a Top Stock?
Motley Fool
Sat, 12/8/12 - 11:01 am
Arena Pharmaceuticals
Belviq
weight loss
obesity
1 Deal Arena Investors Might Have Missed
Motley Fool
Sun, 12/2/12 - 11:52 am
Arena Pharmaceuticals
Belviq
weight loss
obesity
Increased Insurance Coverage: A Big Step For Anti-Obesity Drug Manufacturers
Seeking Alpha
Sun, 11/25/12 - 11:13 am
obesity
weight loss
Good News for Vivus and Arena
Motley Fool
Sat, 11/24/12 - 11:37 am
Vivus
Arena
weight loss
obesity
Does VIVUS Need a Partner?
Motley Fool
Sat, 11/10/12 - 08:27 am
Vivus
Qsymia
weight loss
obesity
Arena Looks To Be The Clear Winner In The Weight Loss Space
Seeking Alpha
Sun, 11/4/12 - 10:27 am
Arena Pharmaceuticals
Vivus
Qsymia
weight loss
obesity
Belviq
GI Dynamics moves toward FDA approval for weight-loss tech
Wed, 10/31/12 - 11:02 pm
GI Dynamics
FDA
weight loss
Weight loss: GI Dynamic wins full FDA approval for ENDO pivotal trial
Tue, 10/30/12 - 11:17 pm
weight loss
GI Dynamics
FDA
Endo
clinical trials
Analysts Objectivity in Coverage of the Obesity Space
Motley Fool
Sun, 10/28/12 - 11:43 am
obesity
weight loss
Orexigen
Arena Pharmaceuticals
A Looming Threat for Arena and VIVUS
Motley Fool
Sun, 10/28/12 - 11:41 am
Arena Pharmaceuticals
Vivus
Orexigen
weight loss
obesity
Weight-loss: Repeat treatments with GI Dynamics' EndoBarrier may extend benefits
Tue, 10/23/12 - 11:09 pm
weight loss
GI Dynamics
EndoBarrier

Pages